Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

From Polymorphs of Racemic Compounds to Enantiopure Crystals

Ziel

The molecular building blocks of life—such as sugars and amino acids—are of only one handedness. This broken molecular symmetry has important consequences for bioactive compounds: a molecule of one handedness can be an effective medicine while its mirror image is extremely toxic. Unfortunately, common chemical processes automatically yield both left- and right-handed molecules (i.e. enantiomers), and routes towards single handedness are often complicated, cumbersome, and costly. Therefore, there is an urgent need for simple, scalable, sustainable, and economical routes to obtain enantiomerically pure molecules.
Recently, we developed a radically new method to convert mixtures of both enantiomers into the desired form by exploiting crystallization. Our process already works on a variety of compounds and is exceptionally fast. However, to transform this fundamental breakthrough into a practical manufacturing method, we must broaden the range of compatible molecules, scale up and integrate the process, and establish a clear path to commercialization.
This ERC Proof-of-Concept project will validate both the technical feasibility and the commercial viability of our method. Commercially, we will conduct a systematic market analysis with trusted industrial partners, identify high-value pharmaceutical targets, and refine our intellectual-property and business strategy for licensing, contract research, or direct production.
Using these steps, CHIRAL-MORPHS promises a cheaper, faster, and more sustainable path to enantiomerically pure building blocks. If successful, it will remove a key bottleneck in the manufacture of chiral medicines, shorten drug-development timelines, and open broad opportunities across the pharmaceutical, agrochemical, and fine-chemical industries.

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) ERC-2025-POC

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Gastgebende Einrichtung

STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN
Netto-EU-Beitrag
€ 150 000,00
Gesamtkosten
Keine Daten

Begünstigte (1)